Tuesday, August 29, 2023

First 10 drugs for Medicare price negotiations chosen

First 10 drugs for Medicare price negotiations chosen

Article Excerpt: "Makers of the drugs have 30 days to agree to participate. ...As a key provision of the Inflation Reduction Act enacted last year, the government will begin negotiating a fair market price for the widely used drugs, which include Bristol-Myers Squibb’s Eliquis, Johnson & Johnson’s Xarelto and Eli Lilly/Boehringer Ingelheim’s Jardiance, among others. Makers of the drugs have 30 days to agree to participate or face steep excise taxes or choose to withdraw their products from coverage by Medicare. The IRA mandates that up to a certain number of drugs will be added annually to the negotiations. The pharmaceutical industry, which fought the..."



Resource: www.politico.com